News

A quarter of hypertensive Medicare enrollees are nonadherent


 

FROM MMWR

References

Over 26% of Medicare part D enrollees aged 65 years and over are not taking their antihypertensive drugs properly, according to a report published online Sept. 13 in MMWR.

An analysis of 2014 data showed that 4.9 million hypertensive Medicare patients were taking an incorrect dose of their medication or were not taking it at all, reported Matthew Ritchey, DPT of the Centers for Disease Control and Prevention’s division for heart disease and stroke prevention, and his associates (MMWR. 2016 Sep 13:65).

Nonadherence rates varied considerably by race and ethnicity, with American Indians/Alaska Natives the highest at 39%, followed by blacks at 36%, Hispanics at 34%, Asian/Pacific Islanders at 26%, and white non-Hispanics at 24%, the investigators noted.

The analysis included 18.5 million part D beneficiaries who filled two or more antihypertensive prescriptions in the same therapeutic class on different dates within a period of more than 90 days in 2014.

rfranki@frontlinemedcom.com

Recommended Reading

Rises in LDL and HDL cholesterol, triglycerides tied to lower diabetes risk
MDedge Endocrinology
Lipid screening in young adults still unsettled
MDedge Endocrinology
Metabolic factors link NAFLD with carotid atherosclerosis
MDedge Endocrinology
PCSK9 inhibitors flunk cost-effectiveness test
MDedge Endocrinology
AHA: Limit children’s added sugar intake to 25 g/day
MDedge Endocrinology
VIDEO: PCSK9 inhibitor can nearly replace need for apheresis in HeFH
MDedge Endocrinology
VIDEO: Moderate LDL, SBP reductions slash cardiovascular events 90% over time
MDedge Endocrinology
VIDEO: Apheresis shows promise for refractory angina with high Lp(a)
MDedge Endocrinology
High free T4 levels linked to sudden cardiac death
MDedge Endocrinology
Four-step screen IDs silent heart attack in type 2 diabetes
MDedge Endocrinology